Table 1.
Cancer types and the number of samples used from The Cancer Genome Atlas (TCGA).
| Cancer Type | Normal Samples | Tumor Samples |
|---|---|---|
| Bladder urothelial carcinoma (BLCA) | 19 | 408 |
| Breast invasive carcinoma (BRCA) | 113 | 1102 |
| Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC) | 3 | 306 |
| Cholangiocarcinoma (CHOL) | 9 | 36 |
| Colon adenocarcinoma (COAD) | 41 | 287 |
| Kidney chromophobe (KICH) | 25 | 66 |
| Kidney renal clear cell carcinoma (KIRC) | 72 | 534 |
| Kidney renal papillary cell carcinoma (KIRP) | 32 | 291 |
| Liver hepatocellular carcinoma (LIHC) | 50 | 374 |
| Lung adenocarcinoma (LUAD) | 59 | 517 |
| Lung squamous cell carcinoma (LUSC) | 51 | 502 |
| Prostate adenocarcinoma (PRAD) | 52 | 498 |
| Stomach adenocarcinoma (STAD) | 35 | 415 |
| Head and neck squamous cell carcinoma (HNSC) | 44 | 522 |
| Thyroid carcinoma (THCA) | 59 | 513 |
| Uterine corpus endometrial carcinoma (UCEC) | 24 | 177 |
| Total | 688 | 6548 |